Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and illness. Nature 461, 1071–1078 (2009).
Lieber, M. R. The mechanism of double-strand DNA break repair by the nonhomologous DNA finish-becoming a member of pathway. Annu. Rev. Biochem. 79, 181–211 (2010).
O’Connor, M. J. Targeting the DNA injury response in most cancers. Mol. Cell 60, 547–560 (2015).
Mohiuddin, I. S. & Kang, M. H. DNA-PK as an rising therapeutic goal in most cancers. Front. Oncol. 9, 635 (2019).
Sung, P. & Klein, H. Mechanism of homologous recombination: mediators and helicases tackle regulatory capabilities. Nat. Rev. Mol. Cell Biol. 7, 739–750 (2006).
Yang, F., Teves, S. S., Kemp, C. J. & Henikoff, S. Doxorubicin, DNA torsion, and chromatin dynamics. Biochim. Biophys. Acta Rev. Cancer 1845, 84–89 (2014).
Davis, A. J., Chen, B. P. C. & Chen, D. J. DNA-PK: a dynamic enzyme in a flexible DSB repair pathway. DNA Repair 17, 21–29 (2014).
Chang, H. H. Y., Pannunzio, N. R., Adachi, N. & Lieber, M. F. R. Non-homologous DNA finish becoming a member of and different pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol. 18, 495–506 (2017).
Jette, N. & Lees-Miller, S. P. The DNA-dependent protein kinase: a multifunctional protein kinase with roles in DNA double strand break repair and mitosis. Prog. Biophys. Mol. Biol. 117, 194–205 (2015).
Harnor, S. J., Brennan, A. & Cano, C. Targeting DNA-dependent protein kinase for most cancers remedy. ChemMedChem 12, 895–900 (2017).
Fok, J. H. L. et al. AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib exercise. Nat. Commun. 10, 5065 (2019).
Yang, H. et al. MTOR kinase construction, mechanism and regulation. Nature 497, 217–223 (2013).
Chaplin, A. Ok. et al. Dimers of DNA-PK create a stage for DNA double-strand break repair. Nat. Struct. Mol. Biol. 28, 13–19 (2021).
Boulton, S., Kyle, S., Yalçintepe, L. & Durkacz, B. W. Wortmannin is a potent inhibitor of DNA double strand break however not single strand break repair in Chinese hamster ovary cells. Carcinogenesis 17, 2285–2290 (1996).
Walker, E. H. et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell 6, 909–919 (2000).
Hardcastle, I. R. et al. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) utilizing a small-molecule library strategy. J. Med. Chem. 48, 7829–7846 (2005).
Goldberg, F. W. et al. The discovery of 7-methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor. J. Med. Chem. 63, 3461–3471 (2020).
Zenke, F. T. et al. Pharmacologic inhibitor of DNA-PK, M3814, potentiates radiotherapy and regresses human tumors in mouse fashions. Mol. Cancer Ther. 19, 1091–1101 (2020).
van Bussel, M. T. J. et al. A primary-in-man part 1 research of the DNA-dependent protein kinase inhibitor peposertib (previously M3814) in sufferers with superior strong tumours. Br. J. Cancer 124, 728–735 (2021).
Wise, H. C. et al. Activity of M3814, an oral DNA-PK inhibitor, together with topoisomerase II inhibitors in ovarian most cancers fashions. Sci. Rep. 9, 18882 (2019).
Sibanda, B. L., Chirgadze, D. Y., Ascher, D. B. & Blundell, T. L. DNA-PKcs construction suggests an allosteric mechanism modulating DNA double-strand break repair. Science 355, 520–524 (2017).
Chen, X. et al. Structure of an activated DNA-PK and its implications for NHEJ. Mol. Cell 81, 801-810 (2021).
Sharif, H. et al. Cryo-EM construction of the DNA-PK holoenzyme. Proc. Natl Acad. Sci. USA 114, 7367–7372 (2017).
Chen, S. et al. Structural foundation of lengthy-vary to quick-vary synaptic transition in NHEJ. Nature https://doi.org/10.1038/s41586-021-03458-7 (2021).
Yin, X., Liu, M., Tian, Y., Wang, J. & Xu, Y. Cryo-EM construction of human DNA-PK holoenzyme. Cell Res. 27, 1341–1350 (2017).
Chaplin, A. Ok. et al. Cryo-EM of NHEJ supercomplexes supplies insights into DNA repair. Mol. Cell 81, 3400–3409 (2021).
Davis, A. J., Lee, Ok. J. & Chen, D. J. The N-terminal area of the DNA-dependent protein kinase catalytic subunit is required for its DNA double-stranded break-mediated activation. J. Biol. Chem. 288, 7037–7046 (2013).
Graham, T. G. W., Walter, J. C. & Loparo, J. J. Two-stage synapsis of DNA ends throughout non-homologous finish becoming a member of. Mol. Cell. 61, 850–858 (2016).
Radoux, C. J., Olsson, T. S. G., Pitt, W. R., Groom, C. R. & Blundell, T. L. Identifying interactions that decide fragment binding at protein hotspots. J. Med. Chem. 59, 4314–4325 (2016).
Hajduk, P. J., Huth, J. R. & Tse, C. Predicting protein druggability. Drug Discov. 10, 1675–1682 (2005).
Lai, A. C. & Crews, C. M. Induced protein degradation: an rising drug discovery paradigm. Nat. Rev. Drug Discov. 16, 101–114 (2017).
Sun, X. et al. Protacs: nice alternatives for academia and trade. Signal Transduct. Target. Ther. 4, 64 (2019).
Liang, S. et al. Stages, scaffolds and strings in the spatial organisation of non-homologous finish becoming a member of: insights from X-ray diffraction and cryo-EM. Prog. Biophys. Mol. Biol. 163, 60–73 (2020).
Menolfi, D. & Zha, S. ATM, ATR and DNA-PKcs kinases—the classes from the mouse fashions: inhibition ≠ deletion. Cell Biosci. 10, 8 (2020).
Bokori-Brown, M. et al. Cryo-EM construction of lysenin pore elucidates membrane insertion by an aerolysin household protein. Nat. Commun. 7, 11293 (2016).
Tegunov, D. & Cramer, P. Real-time cryo-electron microscopy information preprocessing with Warp. Nat. Methods 16, 1146–1152 (2019).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. CryoSPARC: algorithms for speedy unsupervised cryo-EM construction dedication. Nat. Methods 14, 290–296 (2017).
Punjani, A., Brubaker, M. A. & Fleet, D. J. Building proteins in a day: environment friendly 3D molecular construction estimation with electron cryomicroscopy. IEEE Trans. Pattern Anal. Mach. Intell. 39, 706–718 (2017).
Rosenthal, P. B. & Henderson, R. Optimal dedication of particle orientation, absolute hand, and distinction loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721–745 (2003).
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory analysis and evaluation. J. Comput. Chem. 25, 1605–1612 (2004).
Pettersen, E. F., et al. UCSF ChimeraX: construction visualization for researchers, educators, and builders. Protein Sci. 30, 70-82 (2021).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, Ok. Features and improvement of Coot. Acta Crystallogr. D 66, 486–501 (2010).